AJP - Renal Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Renal Physiol 280: F607-F618, 2001;
0363-6127/01 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (25)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Downey, P.
Right arrow Articles by Bonventre, J. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Downey, P.
Right arrow Articles by Bonventre, J. V.
Vol. 280, Issue 4, F607-F618, April 2001

Renal concentrating defect in mice lacking group IV cytosolic phospholipase A2

Patricio Downey1,2, Adam Sapirstein1,3, Eileen O'Leary1,5, Tian-Xiao Sun1,2, Dennis Brown1,4, and Joseph V. Bonventre1,5

1 Medical and Anesthesia Services, Massachusetts General Hospital, Charlestown 02129; Departments of 2 Medicine, 3 Anesthesia, and 4 Pathology, Harvard Medical School, Boston 02114; and 5 Harvard-Massachusetts Institute of Technology Division of Health Sciences and Technology, Cambridge, Massachusetts 02129

Eicosanoids regulate various cellular functions that are important in physiological and pathophysiological processes. Arachidonic acid is released from membranes by phospholipase A2 (PLA2) activity. Activated macrophages derived from mice lacking the 85-kDa group IV cytosolic PLA2 (cPLA2) have a markedly reduced release of prostaglandin E2 and leukotrienes B4 and C4. Under basal conditions and after furosemide, urinary prostaglandin E2 excretion is reduced in cPLA2-knockout (cPLA2-/-) mice. Serum creatinine, Na+, K+, and Ca2+ concentrations, glomerular filtration rate, and fractional excretion of Na+ and K+ are not different in cPLA2-/- and cPLA2+/+ mice. Maximal urinary concentration is lower in 48-h water-deprived cPLA2-/- mice compared with cPLA2+/+ animals (1,934 ± 324 vs. 3,541 ± 251 mmol/kgH2O). Plasma osmolality is higher (337 ± 5 vs. 319 ± 3 mmol/kgH2O) in cPLA2-/- mice that lose a greater percentage of their body weight (20 ± 2 vs. 13 ± 1%) compared with cPLA2+/+ mice after water deprivation. Vasopressin does not correct the concentrating defect. There is progressive reduction in urinary osmolality with age in cPLA2-/- mice. Membrane-associated aquaporin-1 (AQP1) expression, identified by immunocytochemical techniques, is reduced markedly in proximal tubules of older cPLA2-/- animals but is normal in thin descending limbs. However, Western blot analysis of kidney cortical samples revealed an equivalent AQP1 signal intensity in cPLA2+/+ and cPLA2-/- animals. Young cPLA2-/- mice have normal proximal tubule AQP1 staining. Collecting duct AQP2, -3, and -4 were normally expressed in the cPLA2-/- mice. Thus mice lacking cPLA2 develop an age-related defect in renal concentration that may be related to abnormal trafficking and/or folding of AQP1 in the proximal tubule, implicating cPLA2 in these processes.

mouse; osmolality; kidney concentrating mechanism; prostaglandin; aquaporin; eicosanoid


This article has been cited by other articles:


Home page
Mol. Biol. CellHome page
E. Regan-Klapisz, V. Krouwer, M. Langelaar-Makkinje, L. Nallan, M. Gelb, H. Gerritsen, A. J. Verkleij, and J. A. Post
Golgi-associated cPLA2{alpha} Regulates Endothelial Cell-Cell Junction Integrity by Controlling the Trafficking of Transmembrane Junction Proteins
Mol. Biol. Cell, October 1, 2009; 20(19): 4225 - 4234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N. Schliebe, R. Strotmann, K. Busse, D. Mitschke, H. Biebermann, L. Schomburg, J. Kohrle, J. Bar, H. Rompler, J. Wess, et al.
V2 vasopressin receptor deficiency causes changes in expression and function of renal and hypothalamic components involved in electrolyte and water homeostasis
Am J Physiol Renal Physiol, October 1, 2008; 295(4): F1177 - F1190.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Burtey, M. Riera, E. Ribe, P. Pennekamp, E. Passage, R. Rance, B. Dworniczak, and M. Fontes
Overexpression of PKD2 in the mouse is associated with renal tubulopathy
Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1157 - 1165.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
Y. Li, H. Yamada, Y. Kita, M. Kunimi, S. Horita, M. Suzuki, Y. Endo, T. Shimizu, G. Seki, and T. Fujita
Roles of ERK and cPLA2 in the Angiotensin II-Mediated Biphasic Regulation of Na+-HCO3- Transport
J. Am. Soc. Nephrol., February 1, 2008; 19(2): 252 - 259.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
R. A. Fenton and M. A. Knepper
Mouse Models and the Urinary Concentrating Mechanism in the New Millennium
Physiol Rev, October 1, 2007; 87(4): 1083 - 1112.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
H. Francois, C. Facemire, A. Kumar, L. Audoly, B. Koller, and T. Coffman
Role of Microsomal Prostaglandin E Synthase 1 in the Kidney
J. Am. Soc. Nephrol., May 1, 2007; 18(5): 1466 - 1475.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. A. Wong, Y. Kita, N. Uozumi, and T. Shimizu
Discrete Role for Cytosolic Phospholipase A2{alpha} in Platelets: Studies Using Single and Double Mutant Mice of Cytosolic and Group IIA Secretory Phospholipase A2
J. Exp. Med., August 5, 2002; 196(3): 349 - 357.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online